EUVIMEDEUVIMED entdecken
KorrekturOpen Access · CC BY 4.0

Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”

PPAR Research · 2026-01 · 2026 (1)

DOI: 10.1155/ppar/9796467 ↗

Kurz gefasst

Korrektur in der Zeitschrift PPAR Research, online erschienen am 01.07.2026. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C. Cilibrasi, V. Butta, G. Riva, and A. Bentivegna, “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?,” PPAR Research, vol. 2016 (2016). https://doi.org/10.1155/2016/7175067. In the article titled “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?,” there was an error in Figure 5. Specifically, an incorrect image was selected for the cells in the control group stained for CD133/IP/Ph as it represents untreated GliNS2 cells stained for CD133 as reported in a previous publication by the same author group [1]. The error was introduced by the authors during figure assembly and Figure 5 should be corrected as follows: We apologize for these errors.

Zitieren

APA

(2026). Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”. PPAR Research, 2026(1). https://doi.org/10.1155/ppar/9796467

Vancouver

Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”. PPAR Research. 2026;2026(1). doi:10.1155/ppar/9796467

BibTeX
@article{euvimed2026,
  title = {Correction to “Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma?”},
  journal = {PPAR Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ppar/9796467}
}
Kostenlos starten →